Aggregated SOD1 causes selective death of cultured human motor neurons
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aggregated SOD1 causes selective death of cultured human motor neurons
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-31
DOI
10.1038/s41598-018-34759-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders
- (2017) Masato Hasegawa et al. PHARMACOLOGY & THERAPEUTICS
- Transfer of pathogenic and nonpathogenic cytosolic proteins between spinal cord motor neurons in vivo in chimeric mice
- (2017) Eleanor V. Thomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Large-Scale Production of Mature Neurons from Human Pluripotent Stem Cells in a Three-Dimensional Suspension Culture System
- (2016) Alessandra Rigamonti et al. Stem Cell Reports
- A perspective on stem cell modeling of amyotrophic lateral sclerosis
- (2015) A Sophie de Boer et al. CELL CYCLE
- Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy
- (2015) Shi-Yan Ng et al. Cell Stem Cell
- Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model
- (2015) Chen Benkler et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation
- (2015) Rafaa Zeineddine et al. Molecular Neurodegeneration
- Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS)
- (2015) Phillip Smethurst et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
- (2015) Elvira Valera et al. Neurotherapeutics
- From nucleation to widespread propagation: A prion-like concept for ALS
- (2015) Zuzanna Maniecka et al. VIRUS RESEARCH
- Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure
- (2015) Xuebing Ding et al. Oncotarget
- The role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseases
- (2015) Rafaa Zeineddine et al. Frontiers in Physiology
- Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?
- (2015) Shynrye Lee et al. Experimental Neurobiology
- Experimental transmissibility of mutant SOD1 motor neuron disease
- (2014) Jacob I. Ayers et al. ACTA NEUROPATHOLOGICA
- Uptake of Shiga-toxigenicEscherichia coli SubAB by HeLa cells requires an actin- and lipid raft-dependent pathway
- (2014) Sayaka Nagasawa et al. CELLULAR MICROBIOLOGY
- Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms
- (2014) Leslie I. Grad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
- (2014) Hien T. Tran et al. Cell Reports
- Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease
- (2014) Sangjune Kim et al. Experimental Neurobiology
- Protein aggregation in amyotrophic lateral sclerosis
- (2013) Anna M. Blokhuis et al. ACTA NEUROPATHOLOGICA
- Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
- (2013) Kiran Yanamandra et al. NEURON
- Prion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains
- (2013) Takashi Nonaka et al. Cell Reports
- TRiC’s tricks inhibit huntingtin aggregation
- (2013) Sarah H Shahmoradian et al. eLife
- Altered astrocytic response to activation in SOD1G93Amice and its implications on amyotrophic lateral sclerosis pathogenesis
- (2012) Chen Benkler et al. GLIA
- Filamentous Influenza Virus Enters Cells via Macropinocytosis
- (2012) J. S. Rossman et al. JOURNAL OF VIROLOGY
- Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in vitro
- (2012) Terrell E. Brotherton et al. NEUROBIOLOGY OF DISEASE
- Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis
- (2011) Karin Forsberg et al. ACTA NEUROPATHOLOGICA
- Protein aggregates in Huntington's disease
- (2011) Montserrat Arrasate et al. EXPERIMENTAL NEUROLOGY
- Intermolecular transmission of superoxide dismutase 1 misfolding in living cells
- (2011) L. I. Grad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells
- (2011) Christian Münch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
- (2010) Jeffrey D. Rothstein ANNALS OF NEUROLOGY
- Induction of Protective Immunity by Vaccination With Wild-Type Apo Superoxide Dismutase 1 in Mutant SOD1 Transgenic Mice
- (2010) Shigeko Takeuchi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
- (2010) Daryl A Bosco et al. NATURE NEUROSCIENCE
- Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
- (2009) Lei Bu et al. NATURE
- Defining Macropinocytosis
- (2009) Markus C. Kerr et al. TRAFFIC
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started